Skip to Main Content
Try STAT+ TODAY
Trending:
The Obesity Revolution
STAT+
Biotech
Health
Subscribe Now To access exclusive content, subscribe to STAT+
View Latest View the latest STAT+ stories
Insurance
STAT+

DaVita faces another probe over ties to kidney care charity

  • Bob Herman

By Bob Herman Feb. 23, 2023

Reprints
DaVita building
The D.C. attorney general is investigating the dialysis provider DaVita and its ties to the nonprofit American Kidney Fund. Dominic Sagar

The Office of the Attorney General for the District of Columbia is investigating DaVita, one of the largest dialysis providers in the country, and its ties to the nonprofit American Kidney Fund.

DaVita disclosed the new “civil investigative demand” in its latest annual financial filing to investors. The D.C. attorney general is specifically looking at “communications with AKF, documents relating to donations to the AKF, and communications with patients, providers, and insurers regarding the AKF.” The probe covers everything from January 2016 to the present day. DaVita’s competitor, Fresenius, similarly disclosed it received a subpoena from the D.C. attorney general’s office.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

About the Author Reprints

Bob Herman

Bob Herman

Business of Health Care Reporter

Bob Herman is a business of health care reporter at STAT. He covers hospitals, health insurance, and other corners of the industry — with a goal of explaining and shining light on the massive amount of money flowing through the system.

Tags

Create a display name to comment

This name will appear with your comment

Tanzania reports a Marburg outbreak, Africa’s second this year
Tanzania reports a Marburg outbreak, Africa’s second this year
‘We’re getting much more aggressive’: Microsoft’s Nuance adds GPT-4…
‘We’re getting much more aggressive’: Microsoft’s Nuance adds GPT-4 AI to its medical note-taking tool
In a lab pushing the boundaries of biology, an…
In a lab pushing the boundaries of biology, an embedded ethicist keeps scientists in check
Cerebral and other telehealth startups face new legal and…
Cerebral and other telehealth startups face new legal and regulatory challenges over ad models
Patient groups balk at former AstraZeneca official negotiating U.K.-India…
Patient groups balk at former AstraZeneca official negotiating U.K.-India free trade deal
Altimmune’s obesity drug fails to stand out from blockbuster…
Altimmune’s obesity drug fails to stand out from blockbuster treatments in early data

Recommended Stories